Mycetoma

Clinics in Dermatology

Volumn 25, Issue 2, 2007, Pages 195-202

  Welsh, Oliverio ^a   Vera Cabrera, Lucio ^a   Salinas Carmona, Mario Cesar ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; CIPROFLOXACIN; COTRIMOXAZOLE; DAPSONE; GARENOXACIN; GATIFLOXACIN; IMIPENEM; ISONIAZID; ITRACONAZOLE; KETOCONAZOLE; LINEZOLID; MINOCYCLINE; MOXIFLOXACIN; NETILMICIN; OXAZOLIDINONE DERIVATIVE; OXYTETRACYCLINE; POSACONAZOLE; RIFAMPICIN; STREPTOMYCIN; SULFADIAZINE; SULFANILAMIDE; TERBINAFINE; VORICONAZOLE;

ACTINOMYCES; ACTINOMYCETOMA; ANEMIA; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EUMYCETOMA; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LABORATORY DIAGNOSIS; LEUKOPENIA; MYCETOMA; PRIORITY JOURNAL; PROGNOSIS; PUS; RASH; SKIN ABSCESS; SKIN FISTULA; SKIN NODULE; T LYMPHOCYTE; TROPICS;

ANIMALS; HUMANS; MADUROMYCOSIS;

EID: 33847620729     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2006.05.011     Document Type: Article

References (52)

1. Lavalle P. New data on the etiology of mycetoma in Mexico and on its pathogenesis. Gac Med Mex 96 (1966) 545-574
2. Lopez Martinez R., Mendez Tovar L.J., Lavalle P., Welsh O., Saul A., and Macotela Ruiz E. Epidemiology of mycetoma in Mexico: study of 2105 cases. Gac Med Mex 128 (1992) 477-481
3. Mahgoub E.S., and Murray I.G. Mycetoma (1973), Williams Heinemann Medical Books, London 115
4. Mariat F., Destombes P., and Segretain G. The mycetomas: clinical features, pathology, etiology and epidemiology. Contrib Microbiol Immunol 4 (1977) 1-39
5. Ndiaye B., Develoux M., Langlade M.A., and Kane A. Actinomycotic mycetoma. Apropos of 27 cases in Dakar; medical treatment with cotrimoxazole. Ann Dermatol Venereol 121 (1994) 161-165
6. Develoux M., Ndiaye B., and Dieng M.T. Mycetomas in Africa. Sante 5 (1995) 211-217
7. Rodriguez-Nava V., Couble A., Molinard C., Sandoval H., Boiron P., and Laurent F. Nocardia mexicana sp. nov., a new pathogen isolated from human mycetomas. J Clin Microbiol 42 (2004) 4530-4535
8. Bakker X.R., Spauwen P.H., and Dolmans W.M. Mycetoma of the hand caused by Gordona terrae: a case report. J Hand Surg [Br] 29 (2004) 188-190
9. Ahmed A.O., van Leeuwen W., Fahal A., van de Sande W., Verbrugh H., and van Belkum A. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 4 (2004) 566-574
10. Welsh O., Salinas M.C., and Rodriguez M.A. Mycetoma. In: Hoeprich P.D., Jordan M.C., and Ronald A.R. (Eds). Infectious disease. 5th ed. (1994), J.B. Lippincott Co, Philadelphia (Pa) 1405
11. Beaman B.L., Saubolle M.A., and Wallace R.J. Nocardia, Rhodococcus, Streptomyces, Oerskovia, and other aerobic Actinomycetes of medical importance. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., and Yolken R.H. (Eds). Manual of clinical microbiology. 6th ed. (1995), ASM Press, Washington (DC) 379-397
12. Muir D.B., and Pritchard R.C. Use of the BioMerieux ID 32C yeast identification system for identification of aerobic actinomycetes of medical importance. J Clin Microbiol 35 (1997) 3240-3243
13. Butler W.R., Kilburn J.O., and Kubica G.P. High-performance liquid chromatography analysis of mycolic acids as an aid in laboratory identification of Rhodococcus and Nocardia species. J Clin Microbiol 25 (1987) 2126-3131
14. Patel J.B., Wallace Jr. R.J., Brown-Elliott B.A., et al. Sequence-based identification of aerobic actinomycetes. J Clin Microbiol 42 (2004) 2530-2540
15. Kano R., Hattori Y., Murakami N., et al. The first isolation of Nocardia veterana from a human mycetoma. Microbiol Immunol 46 (2002) 409-412
16. Trujillo M.E., and Goodfellow M. Polyphasic taxonomic study of clinically significant actinomadurae including the description of Actinomadura latina sp. nov. Zentralbl Bakteriol 285 (1997) 212-333
17. Salinas-Carmona M.C., Welsh O., and Casillas S.M. Enzyme-linked immunosorbent assay for serological diagnosis of Nocardia brasiliensis and clinical correlation with mycetoma infections. J Clin Microbiol 31 (1993) 2901-2906
18. Yera H., Bougnoux M.E., Jeanrot C., Baixench M.T., De Pinieux G., and Dupouy-Camet J. Mycetoma of the foot caused by Fusarium solani: identification of the etiologic agent by DNA sequencing. J Clin Microbiol 41 (2003) 1805-1808
19. Fahal A.H., Sheik H.E., Homeida M.M., Arabi Y.E., and Mahgoub E.S. Ultrasonographic imaging of mycetoma. Br J Surg 84 (1997) 1120-1122
20. Ganguli S.N., and Hershkop M. Bone scintigraphy of Madura foot. Clin Nucl Med 24 (1999) 284-285
21. Czechowski J., Nork M., Haas D., Lestringant G., and Ekelund L. MR and other imaging methods in the investigation of mycetomas. Acta Radiol 42 (2001) 24-26
22. Melendro E.l., Contreras M.F., Ximenez C., Garcia-Maynez A.M., and Ortiz-Ortiz L. Changes in host resistance caused by Nocardia brasiliensis in mice: cross-protection against Listeria monocytogenes. Int Arch Allergy Appl Immunol 57 (1978) 74-81
23. Beaman B.L., and Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev 7 (1994) 213-264
24. Beaman B.L., Goldstein E., Gershwin M.E., Maslan S., and Lippert W. Lung response to congenitally athymic (nude), heterozygous, and Swiss Webster mice to aerogenic and intranasal infection by Nocardia asteroides. Infect Immun 22 (1978) 867-877
25. Vera-Cabrera L., Rodriguez-Quintanilla M.A., Boiron P., Salinas-Carmona M.C., and Welsh O. Experimental mycetoma by Nocardia brasiliensis in rats. J Mycol Med 8 (1998) 183-187
26. Kaufmann S.H.E. Immunity to intracelullar bacteria. Annu Rev Immunol 11 (1993) 129-163
27. Deem R.L., Doughty F.A., and Beeman B.L. Immunologically specific direct T lymphocyte mediated killing of Nocardia asteroides. J Immunol 130 (1983) 2401-2406
28. Mahgoub E.S., Gumaa S.A., and EL Hassan A.M. Immunological status of mycetoma patients. Bull Soc Pathol Exot Filiales 70 (1977) 48-54
29. Gonzalez Ochoa A., and Baranda F. A cutaneous test for diagnosis of actinomycotic mycetoma caused by Nocardia brasiliensis. Rev Inst Salubr Enferm Trop 13 (1953) 189-197
30. Salinas-Carmona M.C., and Pérez-Rivera I. Humoral immunity through IgM protects mice from an experimental actinomycetoma infection by Nocardia brasiliensis. Infect Immun 72 (2004) 5597-5604
31. Beaman B.L., Gershwin M.E., Ahmed A., Scates S.M., and Deem R. Response of CBA/N × DBA2/F1 mice to Nocardia asteroides. Infect Immun 35 (1982) 111-116
32. Angeles A.M., and Sugar A.M. Identification of a common immunodominant protein in culture filtrates of three Nocardia species and use in etiologic diagnosis of mycetoma. J Clin Microbiol 25 (1987) 2278-2280
33. Angeles A.M., and Sugar A.M. Rapid diagnosis of nocardiosis with an enzyme immunoassay. J Infect Dis 155 (1987) 292-296
34. Ortiz-Ortiz L., and Bojalil L.F. Delayed skin reactions to cytoplasmic extracts of Nocardia organisms as a means of diagnosis and epidemiological study of Nocardia infection. Clin Exp Immunol 12 (1972) 225-229
35. Ortiz-Ortiz L., Bojalil L.F., and Contreras M.F. Delayed hypersensitivity to polysaccharides from Nocardia. J Immunol 108 (1972) 1409-1413
36. Welsh O. Mycetoma. Int J Dermatol 30 (1991) 387-398
37. Mahgoub E.S. Medical management of mycetoma. Bull World Health Organ 54 (1976) 303-310
38. Gomez A., Saul A., Bonifaz A., and Lopez M. Amoxicillin and clavulanic acid in the treatment of actinomycetoma. Int J Dermatol 32 (1993) 218-220
39. Welsh O., Sauceda E., Gonzalez J., and Ocampo J. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. J Am Acad Dermatol 17 (1987) 443-448
40. Wallace Jr. R.J., Septimus E.J., Musher D.M., and Martin R.R. Disk diffusion susceptibility testing of Nocardia species. J Infect Dis 135 (1977) 568-576
41. Wilson R.W., Steingrube V.A., Brown B.A., et al. Recognition of a Nocardia transvalensis complex by resistance to aminoglycosides, including amikacin, and PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 35 (1997) 2235-2242
42. Vera-Cabrera L., Gomez-Flores A., Escalante-Fuentes W.G., and Welsh O. In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis. Antimicrob Agents Chemother 45 (2001) 3629-3630
43. Gomez-Flores A., Welsh O., Said-Fernandez S., Lozano-Garza G., Tavarez-Alejandro R.E., and Vera-Cabrera L. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother 48 (2004) 832-837
44. Moylett E.H., Pacheco S.E., Brown-Elliott B.A., et al. Clinical experience with linezolid for the treatment of nocardia infection. Clin Infect Dis 36 (2003) 313-318
45. Vera-Cabrera L., Gonzalez E., Choi S.H., and Welsh O. In vitro activities of new antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother 48 (2004) 602-604
46. Vera-Cabrera L., Ochoa-Felix E.Y., Gonzalez G., Tijerina R., Choi S.H., and Welsh O. In vitro activities of new quinolones and oxazolidinones against Actinomadura madurae. Antimicrob Agents Chemother 48 (2004) 1037-1039
47. Mellinghoff I.K., Winston D.J., Mukwaya G., and Schiller G.J. Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis 34 (2002) 1648-1650
48. Gonzalez G.M., Tijerina R., Najvar L.K., et al. Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays. Antimicrob Agents Chemother 47 (2003) 1436-1438
49. Hay R.J. Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. Br J Dermatol Suppl 56 (1999) 36-40
50. Paugam A., Tourte-Schaefer C., Keita A., Chemla N., and Chevrot A. Clinical cure of fungal Madura foot with oral itraconazole. Cutis 60 (1997) 191-193
51. Lacroix C., de Kerviler E., Morel P., Derouin F., and Feuilhade de Chavin M. Madurella mycetomatis mycetoma treated successfully with oral voriconazole. Br J Dermatol 152 (2005) 1067-1068
52. Ahmed A.O., van de Sande W.W., van Vianen W., et al. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob Agents Chemother 48 (2004) 2742-2746